Veklury and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veklury (remdesivir) and Decadron (dexamethasone). Common drug interactions include bradycardia among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Veklury and Decadron. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Veklury?

Veklury has active ingredients of remdesivir. eHealthMe is studying from 2,753 Veklury users. Check the latest studies of Veklury.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

On Jul, 09, 2026

85 people who take Veklury and Decadron together, and have interactions are studied.

What are the common drug interactions of Veklury and Decadron, by gender? *:

female:

Bradycardia (abnormally slow heart action)
Acute respiratory distress syndrome
Blood pressure decreased
Dehydration (dryness resulting from the removal of water)
International normalised ratio increased
Oral candidiasis (fungal infection of mouth)
Oxygen saturation decreased
Alanine aminotransferase increased
Aspartate aminotransferase increased
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)

male:

Bradycardia (abnormally slow heart action)
Blood urea increased
Hepatic enzyme increased
Acute myocardial infarction (acute heart attack)
Cardiac failure
Cardiogenic shock (inadequate circulation of blood)
Hypotension (abnormally low blood pressure)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Renal infarct (kidney damage due to lack of blood supply)

What are the common drug interactions of Veklury and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Erythema (redness of the skin)
Pruritus (severe itching of the skin)
Pneumomediastinum (air is present in the mediastinum)

30-39:

Bradycardia (abnormally slow heart action)
Liver disorder (liver diseases)

40-49:

Bacterial infection
Bradycardia (abnormally slow heart action)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

50-59:

Bradycardia (abnormally slow heart action)
Hepatic enzyme increased
Renal infarct (kidney damage due to lack of blood supply)
Blood urea increased
Blood creatine phosphokinase increased
Fibrin d dimer increased
Pancreatitis acute (sudden inflammation of pancreas)
Platelet count decreased
White blood cell count increased
Drug eruption (adverse drug reaction of the skin)

60+:

Renal impairment (severely reduced kidney function)
Bradycardia (abnormally slow heart action)
Cardiac failure
Acute myocardial infarction (acute heart attack)
Acute respiratory distress syndrome
Blood pressure decreased
Cardiogenic shock (inadequate circulation of blood)
Dehydration (dryness resulting from the removal of water)
Hypotension (abnormally low blood pressure)
International normalised ratio increased

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 7.06%
High Blood Pressure: 6 people, 7.06%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 5 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Veklury and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously